Penmenvy, which protects against five common types of disease-causing bacteria, is cleared for use in people aged 10 through ...
Monico is a custom icon pack designed specifically for the Monobloc solution by crc.studio. It features a collection of versatile icons to enhance your design system, creating a cohesive visual ...
Papua New Guinea's Prime Minister James Marape has asked United States ... He said he is greatly concerned about PNG and other Pacific nations, which have been unjustly subjected to the effects of ...
The Edmonton Oilers have been on a roll when it comes to creating new logos for specialty game nights this season. Earlier in the season, the team was praised for their amazing Day of the Dead logo, ...
This European regulatory review follows the file acceptance by the US FDA on 8 January 2025 for the new prefilled syringe presentation. GSK is also investigating submission of this presentation to ...
Mazda’s new logo sheds 3D elements for a flat design optimized for smartphones. The updated emblem may debut ahead of Mazda’s 105th anniversary on January 30. Depending on the application ...
Bearish flow noted in GSK (GSK) Pharma with 1,694 puts trading, or 4x expected. Most active are 2/7 weekly 34 puts and Jan-27 28 puts, with total volume in those strikes near 1,600 contracts.
GSK (GSK) announced that new drug applications have been accepted for review by the China National Medical Products Administration and submitted to the Japanese Ministry of Health, Labour and ...
If approved, the new presentation will offer a convenient administration option to healthcare professionals Globally, up to 1 in 3 adults will develop shingles in their lifetime 1,2,3,4 Over 25 ...
GSK's vaccine for shingles prevention. This new syringe presentation is designed to simplify the administration process for healthcare providers by eliminating the need to mix a powder and liquid ...
Scientists are working to create a new cancer vaccine that could “detect the undetectable” and stop the disease up to 20 years before it has the chance to develop. Pharmaceutical giant GSK and ...